Nanobac Pharmaceuticals, Incorporated (NNBP)
NNBP Stock Price Chart
Explore Nanobac Pharmaceuticals, Incorporated interactive price chart. Choose custom timeframes to analyze NNBP price movements and trends.
NNBP Company Profile
Discover essential business fundamentals and corporate details for Nanobac Pharmaceuticals, Incorporated (NNBP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
31 Oct 1994
Employees
1.00
CEO
John M. Stanton
Description
Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida.
NNBP Financial Timeline
Browse a chronological timeline of Nanobac Pharmaceuticals, Incorporated corporate events including earnings releases, dividend announcements, and stock splits.
NNBP Stock Performance
Access detailed NNBP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.